Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -271.81% is 29% above its 5-year average of -383.83%, near the high end of its 5-year range (-949.34%–-84.81%).
As of the fiscal period ended Tuesday, June 30, 2026. 46.22% above its 12-month average of -505.41%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -271.81%.
RETURN ON EQUITY (ROE)
-271.81%
RETURN ON EQUITY (ROE) AVG TTM
-505.41%
RETURN ON EQUITY (ROE) AVG 3Y
-590.30%
RETURN ON EQUITY (ROE) AVG 5Y
-383.83%
RETURN ON EQUITY (ROE) AVG 10Y
-216.58%
RETURN ON EQUITY (ROE) AVG 15Y
-121.07%
RETURN ON EQUITY (ROE) AVG 20Y
-97.74%
CURRENT VS TTM AVG
+46.22%
CURRENT VS 3Y AVG
+53.95%
CURRENT VS 5Y AVG
+29.18%
CURRENT VS 10Y AVG
-25.50%
CURRENT VS 15Y AVG
-124.50%
CURRENT VS 20Y AVG
-178.11%
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
-654.94%
vs the sector median at left
BioCardia, Inc.
Market Cap
$16.22M
Return on Equity (ROE)
-271.81%
TTM Avg
-505.41%
3Y Avg
-590.30%
5Y Avg
-383.83%
Market Cap
$15.91M
Return on Equity (ROE)
-348.81%
TTM Avg
-160.92%
3Y Avg
-184.71%
5Y Avg
-151.29%
Market Cap
$16.54M
Return on Equity (ROE)
N/A
TTM Avg
-416.37%
3Y Avg
-259.03%
5Y Avg
-190.00%
Market Cap
$16.58M
Return on Equity (ROE)
-101.76%
TTM Avg
-188.04%
3Y Avg
-167.76%
5Y Avg
-134.95%
Market Cap
$15.30M
Return on Equity (ROE)
-951.92%
TTM Avg
-161.65%
3Y Avg
-122.41%
5Y Avg
-87.71%
Market Cap
$14.28M
Return on Equity (ROE)
-69.47%
TTM Avg
-55.64%
3Y Avg
-44.95%
5Y Avg
-41.56%
Market Cap
$18.77M
Return on Equity (ROE)
N/A
TTM Avg
-3014.83%
3Y Avg
-1589.49%
5Y Avg
-1032.64%
Market Cap
$18.82M
Return on Equity (ROE)
-117.98%
TTM Avg
-84.94%
3Y Avg
-64.05%
5Y Avg
-76.29%
Market Cap
$13.62M
Return on Equity (ROE)
-101.66%
TTM Avg
-140.38%
3Y Avg
-131.64%
5Y Avg
-101.94%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $16.22M | -271.81% | -505.41% | -590.30% | -383.83% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -348.81% | -160.92% | -184.71% | -151.29% |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | N/A | -416.37% | -259.03% | -190.00% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -101.76% | -188.04% | -167.76% | -134.95% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -951.92% | -161.65% | -122.41% | -87.71% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -69.47% | -55.64% | -44.95% | -41.56% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | N/A | -3014.83% | -1589.49% | -1032.64% |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -117.98% | -84.94% | -64.05% | -76.29% |
| IN8bio, Inc. (INAB)vs › | $13.62M | -101.66% | -140.38% | -131.64% | -101.94% |
| Vyome Holdings, Inc. (HIND)vs › | $13.55M | -186.95% | 1198.98% | 241.18% | 112.17% |
ROE
-271.8%
ROA
-154.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -271.81% |
| 2025-12-31 | -919.33% |
| 2025-09-30 | -325.09% |
| 2024-12-31 | -949.34% |
| 2024-09-30 | -280.49% |
| 2023-06-30 | -795.72% |
| 2023-03-31 | -635.95% |
| 2022-12-31 | -243.40% |
| 2022-09-30 | -301.20% |
| 2022-06-30 | -178.04% |
| 2022-03-31 | -176.13% |
| 2021-12-31 | -121.67% |
| 2021-09-30 | -90.60% |
| 2021-06-30 | -84.81% |
| 2021-03-31 | -72.08% |
| 2020-12-31 | -78.24% |
| 2020-09-30 | -377.24% |
| 2020-06-30 | -212.04% |
| 2019-12-31 | -620.59% |
| 2019-09-30 | -285.89% |
| 2018-12-31 | -368.86% |
| 2018-09-30 | -469.80% |
| 2018-06-30 | -230.77% |
| 2018-03-31 | -158.60% |
| 2017-12-31 | -110.63% |
| 2017-09-30 | -177.08% |
| 2017-06-30 | -101.29% |
| 2017-03-31 | -72.31% |
| 2016-12-31 | -50.09% |
| 2016-09-30 | 28.03% |
| 2016-06-30 | 2.35% |
| 2016-03-31 | 2.35% |
| 2015-12-31 | 2.32% |
| 2015-09-30 | 2.14% |
| 2015-06-30 | 1.85% |
| 2015-03-31 | 1.81% |
| 2014-12-31 | 1.73% |
| 2014-09-30 | 1.32% |
| 2014-06-30 | 1.23% |
| 2014-03-31 | 0.81% |
| 2013-12-31 | 0.14% |
| 2013-09-30 | 0.39% |
| 2013-06-30 | 3.56% |
| 2013-03-31 | 2.53% |
| 2012-12-31 | 2.30% |
| 2012-09-30 | -0.14% |
| 2012-06-30 | -8.05% |
| 2012-03-31 | 76.87% |
| 2011-12-31 | 74.50% |
| 2011-09-30 | 71.62% |
| 2011-06-30 | 13.52% |
| 2011-03-31 | -349.44% |
| 2010-12-31 | -350.99% |
| 2010-09-30 | -330.66% |
| 2010-06-30 | -46.06% |
| 2010-03-31 | -39.92% |
| 2009-12-31 | -34.46% |
| 2009-09-30 | -59.21% |
| 2009-06-30 | -54.16% |
| 2009-03-31 | -50.37% |
| 2008-12-31 | -33.99% |
| 2008-09-30 | -10.55% |
| 2008-06-30 | -9.87% |
| 2008-03-31 | -8.45% |
| 2007-12-31 | -11.91% |
| 2007-09-30 | -9.84% |
| 2007-06-30 | -123.11% |
| 2007-03-31 | -91.44% |
| 2006-12-31 | -123.17% |
| 2006-09-30 | -78.70% |
| 2006-06-30 | -79.37% |
| 2006-03-31 | -107.52% |
| 2005-12-31 | -447.16% |
| 2005-09-30 | -426.85% |
| 2005-06-30 | -459.38% |
| 2005-03-31 | -530.25% |
| 2004-12-31 | -90.89% |
| 2004-09-30 | -108.22% |
| 2004-06-30 | -75.02% |
| 2004-03-31 | -44.44% |
| 2003-12-31 | -37.80% |
| 2003-09-30 | -24.99% |
| 2003-06-30 | -28.52% |
